Obstetrics, Gynecology and Reproductive Biology Research
Trial for Endometriosis
A Phase 3B Study to Evaluate Bone Mineral Density with Long-Term Use of the Investigational Medication in Women with Moderate to Severe Pain due to Endometriosis
AGE: 18 - 50 years old
SEX AT BIRTH: Female
HEALTHY PARTICIPANTS: No
SEX AT BIRTH: Female
HEALTHY PARTICIPANTS: No
TYPE: Interventional Drug Study
CONDITION: Endometriosis
CONDITION: Endometriosis
LOCATION: UH Landerbrook Medical Center and UH Ahuja Risman Medical Center
Learn More About This Research Study
For more information, please contact the study nurse coordinator, Bridget Ermlich, RN, at 216-844-8091 or complete the form below.
Study Purpose
The purpose of this research study is to characterize changes in bone mineral density during continuous treatment with the investigational medication for up to 48 months (4 years) and 1 year of post-treatment follow-up in premenopausal women with moderate-to-severe pain associated with endometriosis.
Who Can Participate
Premenopausal women aged 18 – 50 years, who have a diagnosis of moderate to severe pain associated with endometriosis may be eligible to participate.
- STUDY ID# SITE00002089
- NCT05862272